WASHINGTON (Reuters) - A product taken from the blood of people who have been vaccinated for smallpox was approved on Friday to use to treat reactions from the shot, the U.S. Food and Drug Administration said.
The FDA said it had approved DynPort Vaccine Co. LLC's Vaccinia Immune Globulin Intravenous. It is made out of human plasma.